Thrombosis

Conference Coverage

Update of gene therapy in hemophilia A

ATLANTA—Updated trial results have shown that gene therapy can increase factor VIII (FVIII) levels and reduce the need for FVIII infusions in...

Conference Coverage

Caplacizumab improves outcomes in aTTP

ATLANTA—Caplacizumab can improve outcomes in patients with acquired thrombotic thrombocytopenic purpura (aTTP), according to research presented at...

Pages